Biogen’s Controversial Alzheimer’s Drug Was Connected to a Patient Death, Just As the Company Presented Its Final Study Data
To say that Biogen’s Alzheimer’s drug aduhelm is controversial wouldn’t do its rocky road to approval justice. To say it’s complicated is even less satisfying, given that…